Daily time-restricted eating to ease fatigue after blood cancers
Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies
['FUNDING_R01'] · UNIVERSITY OF MARYLAND BALTIMORE · NIH-11187059
This project sees whether limiting eating to a 10-hour daytime window can help people who finished treatment for blood cancers feel less tired.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MARYLAND BALTIMORE (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-11187059 on ClinicalTrials.gov |
What this research studies
You would join a 12-week program where half of participants are asked to eat only during a consistent 10-hour daytime window while the other half continue their usual eating patterns. The study enrolls 96 survivors who are 2 months to 2 years past curative treatment and have moderate to severe fatigue. Researchers will use activity monitors and a phone app to track sleep, activity, and when you eat, with a follow-up visit planned at 24 weeks. Participation includes in-person visits at the study site and regular remote monitoring.
Who could benefit from this research
Good fit: Adults who completed curative treatment for hematologic (blood) cancers 2 months to 2 years ago, report moderate to severe fatigue, and currently eat across more than a 10-hour daily window.
Not a fit: People still receiving cancer therapy, those with only mild fatigue, or those who already limit eating to about 10 hours or less are unlikely to benefit from this specific trial.
Why it matters
Potential benefit: If successful, this could offer a simple, non-drug way to reduce long-lasting fatigue after blood cancer treatment.
How similar studies have performed: Time-restricted eating has shown improvements in metabolism, sleep, and daily rhythms in other populations, but it is largely untested for cancer-related fatigue in blood cancer survivors.
Where this research is happening
BALTIMORE, UNITED STATES
- UNIVERSITY OF MARYLAND BALTIMORE — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KLECKNER, AMBER SIMMONS — UNIVERSITY OF MARYLAND BALTIMORE
- Study coordinator: KLECKNER, AMBER SIMMONS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.